Literature DB >> 23025504

Malakoplakia after renal transplantation in the current era of immunosuppressive therapy: case report and literature review.

C A Leão1, M I S Duarte, C Gamba, J F Ramos, F Rossi, M M Galvão, E David-Neto, W Nahas, M A Shikanai-Yasuda, L C Pierrotti.   

Abstract

Malakoplakia is a rare chronic granulomatous disease of unknown cause. It is thought to be caused by an acquired bactericidal defect of macrophages. Malakoplakia is associated with chronic infections and immunosuppression. Although it occurs mainly in the urinary tract, it has already been reported in almost every organ system. The isolation of bacteria, especially Escherichia coli, is common in malakoplakia patients. Here, we present a case of primary cutaneous malakoplakia in a kidney transplant recipient who had been taking prednisone, tacrolimus, and mycophenolate. Culture of a lesion grew Burkholderia cepacia complex. Treatment with high doses of trimethoprim-sulfamethoxazole was successful. We also present a systematic review of the literature, identifying 4 previously reported cases of malakoplakia after renal transplantation under similar immunosuppressive therapy, most occurring in the urinary tract or perineum and following benign courses to cure. Data in the literature suggest that malakoplakia has become even rarer since changes were made in the immunosuppressive therapy employed after kidney transplantation.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23025504     DOI: 10.1111/tid.12012

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  2 in total

1.  Malakoplakia in Thoracic Transplant Recipients.

Authors:  R J Lane; R Kradin; D Xia; C A Buchan; S Turbett; C N Kotton; M K Mansour
Journal:  Transplant Proc       Date:  2019-01-08       Impact factor: 1.066

2.  Disseminated Mycobacterium Simiae with Pelvic Malakoplakia in an AIDS Patient.

Authors:  Maria Nina Chitasombat; Duangkamon Wattanatranon
Journal:  Clin Med Insights Case Rep       Date:  2015-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.